Top

The International Journal of Cardiovascular Imaging

Published in:

04-01-2024 | Cardiomyopathy | Original Paper

A comparative study of synthetic and venous hematocrit for calculating cardiovascular magnetic resonance-derived extracellular volume

Authors: Jiani Yin, Jie Qin, Wangyan Liu, Yinsu Zhu, Xiaoyue Zhou, Yunfei Wang, Xiaomei Zhu, Yi Xu

Published in: The International Journal of Cardiovascular Imaging | Issue 4/2024

Abstract

The extracellular volume (ECV) fraction derived from cardiac magnetic resonance (CMR) can reflect various pathologies. The application of ECVs was limited by the strict requirement that hematocrit (Hct₀) should be obtained within 24 hours of CMR scan. The aim of this study was to obtain accurate and convenient ECV calculated from the venous Hct and synthetic Hct in CMR. A total of 839 subjects were retrospectively enrolled. The subjects were divided into derivation cohort for local sex-specific models and validation cohort for assessing the accuracy of different ECVs. In the validation cohort, venous Hcts from 7 days before the scan (Hct_1 − 7), outside 7 days (Hct_> 7), the closest day (Hct_closest), and Hct_syn were compared with Hct₀. The agreement and correlation of the conventional ECV (ECV₀) with the corresponding ECVs were analyzed. The factors affecting the accuracy of ECV_syn were assessed. ECV_1–7 and ECV_closest had the best correlation and smallest bias with ECV₀ (R = 0.959 and 0.951, bias = 0.02% and − 0.03%). When using an absolute 2% error as the standard, the performance of ECV_1–7 was the best, with an accuracy of 81.0%, followed by ECV_closest (78.8%), ECV_> 7 (77.2%) and ECV_syn (70.7%). Abnormally low and high Hcts and decreased left ventricular ejection fractions were associated with miscalculation of ECV_syn, especially patients with dilated cardiomyopathy. We recommend extending the time interval between a Hct and a CMR scan to 7 days for ECV calculation. The synthetic ECV should be used cautiously, especially for patients with extremely low or high Hcts, decreased cardiac function, and dilated cardiomyopathy.

Nakamori S, Dohi K, Ishida M et al (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11(1):48–59. https://doi.org/10.1016/j.jcmg.2017.04.006CrossRefPubMed

Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6(3):373–383. https://doi.org/10.1161/CIRCIMAGING.112.000192CrossRefPubMed

Thongsongsang R, Songsangjinda T, Tanapibunpon P et al (2021) Native T1 mapping and extracellular volume fraction for differentiation of myocardial Diseases from normal CMR controls in routine clinical practice. BMC Cardiovasc Disord 21(1):270. https://doi.org/10.1186/s12872-021-02086-3CrossRefPubMedPubMedCentral

Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75. https://doi.org/10.1186/s12968-017-0389-8CrossRefPubMedPubMedCentral

Su MY, Huang YS, Niisato E et al (2020) Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance-derived extracellular volume measurements?. J Cardiovasc Magn Reson 22(1):77. https://doi.org/10.1186/s12968-020-00689-xCrossRefPubMedPubMedCentral

Treibel TA, Fontana M, Maestrini V et al (2016) Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit Sampling. JACC Cardiovasc Imaging 9(1):54–63. https://doi.org/10.1016/j.jcmg.2015.11.008CrossRefPubMed

Raucci FJ, Parra DA, Christensen JT et al (2017) Synthetic hematocrit derived from the longitudinal relaxation of blood can lead to clinically significant errors in measurement of extracellular volume fraction in pediatric and young adult patients. J Cardiovasc Magn Reson 19(1):58. https://doi.org/10.1186/s12968-017-0377-zCrossRefPubMedPubMedCentral

Censi S, Cimaglia P, Barbieri A et al (2021) Performance of synthetic extracellular volume fraction in different cardiac phenotypes from a prospective cohort of patients referred for Cardiac magnetic Resonance. J Magn Reson Imaging 54(2):429–439. https://doi.org/10.1002/jmri.27556CrossRefPubMed

Robison S, Karur GR, Wald RM et al (2018) Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation. J Cardiovasc Magn Reson 20(1):19. https://doi.org/10.1186/s12968-018-0443-1CrossRefPubMedPubMedCentral

10.

Chen W, Doeblin P, Al-Tabatabaee S et al (2022) Synthetic extracellular volume in cardiac magnetic resonance without blood sampling: a reliable tool to replace conventional extracellular volume. Circ Cardiovasc Imaging 15(4):e13745. https://doi.org/10.1161/CIRCIMAGING.121.013745CrossRef

11.

Shang Y, Zhang X, Zhou X et al (2018) Extracellular volume fraction measurements derived from the longitudinal relaxation of blood-based synthetic hematocrit may lead to clinical errors in 3 T cardiovascular magnetic resonance. J Cardiovasc Magn Reson 20(1):56. https://doi.org/10.1186/s12968-018-0475-6CrossRefPubMedPubMedCentral

12.

Laohabut I, Songsangjinda T, Kaolawanich Y et al (2021) Myocardial extracellular volume fraction and T1 mapping by cardiac magnetic resonance compared between patients with and without type 2 diabetes, and the effect of ECV and T2D on cardiovascular outcomes. Front Cardiovasc Med 8:771363. https://doi.org/10.3389/fcvm.2021.771363CrossRefPubMedPubMedCentral

13.

Martinez-Naharro A, Patel R, Kotecha T et al (2022) Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment. Eur Heart J 43(45):4722–4735. https://doi.org/10.1093/eurheartj/ehac363CrossRefPubMedPubMedCentral

14.

Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211(3):698–708. https://doi.org/10.1148/radiology.211.3.r99jn41698CrossRefPubMed

15.

Kositanurit W, Theerasuwipakorn N, Vorasettakarnkij Y et al (2023) Reference values of myocardial native T1 and extracellular volume in patients without structural heart disease and had negative 3T cardiac magnetic resonance adenosine stress test. Int J Cardiol Heart Vasc 45:101181. https://doi.org/10.1016/j.ijcha.2023.101181PubMedPubMedCentral

16.

Cheng BJ, Li TL, Li H et al (2023) Short-term effects of cold spells on hematocrit among adults in Nanjing, China: a distributed-lagged effect analysis. Sci Total Environ 892:164469. https://doi.org/10.1016/j.scitotenv.2023.164469CrossRefPubMed

17.

Rostomily KA, Jones DM, Pautz CM et al (2020) Haemoconcentration, not decreased blood temperature, increases blood viscosity during cold water immersion. Diving Hyperb Med 50(1):24–27. https://doi.org/10.28920/dhm50.1.24-27CrossRefPubMedPubMedCentral

18.

Sennels HP, Jorgensen HL, Hansen AL et al (2011) Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 71(7):532–541. https://doi.org/10.3109/00365513.2011.602422CrossRefPubMed

19.

Thirup P (2003) Haematocrit: within-subject and seasonal variation. Sports Med 33(3):231–243. https://doi.org/10.2165/00007256-200333030-00005CrossRefPubMed

20.

Checinska-Maciejewska Z, Niepolski L, Checinska A et al (2019) Regular cold water swimming during winter time affects resting hematological parameters and serum erythropoietin. J Physiol Pharmacol 70(5). https://doi.org/10.26402/jpp.2019.5.10

21.

Yilmaz S, Ergun S, Celik ES et al (2021) The impact of acute cold water stress on blood parameters, mortality rate and stress-related genes in Oreochromis niloticus, Oreochromis mossambicus and their hybrids. J Therm Biol 100:103049. https://doi.org/10.1016/j.jtherbio.2021.103049CrossRefPubMed

22.

Rosmini S, Bulluck H, Abdel-Gadir A et al (2019) The effect of blood composition on T1 mapping. JACC Cardiovasc Imaging 12(9):1888–1890. https://doi.org/10.1016/j.jcmg.2019.03.018CrossRefPubMed

23.

Hales PW, Kirkham FJ, Clark CA (2016) A general model to calculate the spin-lattice (T1) relaxation time of blood, accounting for haematocrit, oxygen saturation and magnetic field strength. J Cereb Blood Flow Metab 36(2):370–374. https://doi.org/10.1177/0271678X15605856CrossRefPubMed

24.

Nickander J, Lundin M, Abdula G et al (2017) Blood correction reduces variability and gender differences in native myocardial T1 values at 1.5 T cardiovascular magnetic resonance - a derivation/validation approach. J Cardiovasc Magn Reson 19(1):41. https://doi.org/10.1186/s12968-017-0353-7CrossRefPubMedPubMedCentral

25.

Kellman P, Wilson JR, Xue H et al (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14(1):64. https://doi.org/10.1186/1532-429X-14-64PubMedPubMedCentral

26.

Sado DM, Flett AS, Banypersad SM et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436–1441. https://doi.org/10.1136/heartjnl-2012-302346CrossRefPubMed

27.

Engblom H, Kanski M, Kopic S et al (2018) Importance of standardizing timing of hematocrit measurement when using cardiovascular magnetic resonance to calculate myocardial extracellular volume (ECV) based on pre- and post-contrast T1 mapping. J Cardiovasc Magn Reson 20(1):46. https://doi.org/10.1186/s12968-018-0464-9CrossRefPubMedPubMedCentral

28.

Opatril L, Panovsky R, Machal J et al (2021) Extracellular volume quantification using synthetic haematocrit assessed from native and post-contrast longitudinal relaxation T1 times of a blood pool. BMC Cardiovasc Disord 21(1):363. https://doi.org/10.1186/s12872-021-02179-zCrossRefPubMedPubMedCentral

Title: A comparative study of synthetic and venous hematocrit for calculating cardiovascular magnetic resonance-derived extracellular volume
Authors: Jiani Yin
Jie Qin
Wangyan Liu
Yinsu Zhu
Xiaoyue Zhou
Yunfei Wang
Xiaomei Zhu
Yi Xu
Publication date: 04-01-2024
Publisher: Springer Netherlands
Keyword: Cardiomyopathy
Published in: The International Journal of Cardiovascular Imaging / Issue 4/2024
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-023-03044-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A comparative study of synthetic and venous hematocrit for calculating cardiovascular magnetic resonance-derived extracellular volume

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2024

Cardiac magnetic resonance-derived mitral annular plane systolic excursion: a robust indicator for risk stratification after myocardial infarction

Impact of left ventricular inflow-outflow angle on heart failure readmission post-transcatheter aortic valve implantation

Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention

NASCI case of the month: a case of anomalous right coronary artery arising from the pulmonary artery

Left atrial strain is associated with long-term mortality in acute coronary syndrome patients

Halved contrast medium dose coronary dual-layer CT-angiography – phantom study of tube current and patient characteristics